Jump to:
loading...| Preferred Name |
Natalizumab |
|
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00022041 |
|
| Database_Cross_Reference |
NCI_FDA:3JB47N2Q2P MTH:NOCODE MEDCIN:301137 DRUGBANK:DB00108 MSH:D000069442 MTHSPL:3JB47N2Q2P USPMG:MTHU001501 SNOMEDCT_US:414805007 MMSL:d05414 LNC:LP64671-8 NDDF:008765 NDFRT:N0000010565 RXNORM:354770 NDFRT:N0000148870 NCI:C77862 SNOMEDCT_US:414804006 ATC:L04AA23 VANDF:4021508 MMSL:19083 CHV:0000055792 |
|
| label |
Natalizumab |
|
| MCID |
MC00398343 |
|
| PMOID |
PMO:00022041 |
|
| prefixIRI |
pmo:PMO_00022041 |
|
| prefLabel |
Natalizumab |
|
| Synonym |
natalizumab Anti-VLA4 Natalizumab (product) Natalizumab [Chemical/Ingredient] Anti-alpha4 integrin natalizumab (medication) Natalizumab (substance) NATALIZUMAB |
|
| Tree Number |
T6.8.1.84.16.2.6.8.1.3 T6.4.2.1.2.6.8.1.3 T6.8.1.72.4.6.6.8.1.3 T6.8.1.84.12.6.6.8.1.3 |
|
| subClassOf |
Create mapping